Literature DB >> 9986799

Safe determination of susceptibility of Mycobacterium tuberculosis to antimycobacterial agents by flow cytometry.

A V Moore1, S M Kirk, S M Callister, G H Mazurek, R F Schell.   

Abstract

We showed previously that susceptibility testing for Mycobacterium tuberculosis labeled with fluorescein diacetate could be accomplished rapidly by using flow cytometry. However, safety was a major concern because mycobacteria were not killed prior to flow cytometric analysis. In this study, we developed a biologically safe flow cytometric susceptibility test that depends on detection and enumeration of actively growing M. tuberculosis organisms in drug-free and antimycobacterial agent-containing medium. The susceptibilities of 17 clinical isolates of M. tuberculosis to ethambutol, isoniazid, and rifampin were tested by the agar proportion and flow cytometric methods. Subsequently, all flow cytometric susceptibility test samples were inactivated by exposure to paraformaldehyde before analysis with a flow cytometer. Agreement between the results from the two methods was 98%. In addition, the flow cytometric results were available 72 h after the initiation of testing. The flow cytometric susceptibility assay is safe, simple to perform, and more rapid than conventional test methods, such as the BACTEC system and the proportion method.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9986799      PMCID: PMC84439     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  14 in total

Review 1.  A review of the action of isoniazid.

Authors:  J Youatt
Journal:  Am Rev Respir Dis       Date:  1969-05

2.  Effect of isoniazid on biosynthesis in Mycobacterium tuberculosis var. bovis BCG.

Authors:  J W Wimpenny
Journal:  J Gen Microbiol       Date:  1967-06

3.  Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic.

Authors:  M C Raviglione; D E Snider; A Kochi
Journal:  JAMA       Date:  1995-01-18       Impact factor: 56.272

4.  Rapid susceptibility testing of Mycobacterium tuberculosis (H37Ra) by flow cytometry.

Authors:  M A Norden; T A Kurzynski; S E Bownds; S M Callister; R F Schell
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

5.  Determination of minimal inhibitory concentrations of antituberculosis drugs by radiometric and conventional methods.

Authors:  C N Lee; L B Heifets
Journal:  Am Rev Respir Dis       Date:  1987-08

6.  Nationwide survey of drug-resistant tuberculosis in the United States.

Authors:  A B Bloch; G M Cauthen; I M Onorato; K G Dansbury; G D Kelly; C R Driver; D E Snider
Journal:  JAMA       Date:  1994-03-02       Impact factor: 56.272

7.  Evaluation of the BACTEC radiometric method for recovery of mycobacteria and drug susceptibility testing of Mycobacterium tuberculosis from acid-fast smear-positive specimens.

Authors:  G D Roberts; N L Goodman; L Heifets; H W Larsh; T H Lindner; J K McClatchy; M R McGinnis; S H Siddiqi; P Wright
Journal:  J Clin Microbiol       Date:  1983-09       Impact factor: 5.948

8.  MYCOBACTERIA: LABORATORY METHODS FOR TESTING DRUG SENSITIVITY AND RESISTANCE.

Authors:  G CANETTI; S FROMAN; J GROSSET; P HAUDUROY; M LANGEROVA; H T MAHLER; G MEISSNER; D A MITCHISON; L SULA
Journal:  Bull World Health Organ       Date:  1963       Impact factor: 9.408

9.  Determination of in vitro susceptibility of Mycobacterium tuberculosis to cephalosporins by radiometric and conventional methods.

Authors:  L B Heifets; M D Iseman; J L Cook; P J Lindholm-Levy; I Drupa
Journal:  Antimicrob Agents Chemother       Date:  1985-01       Impact factor: 5.191

10.  Interlaboratory drug susceptibility testing of Mycobacterium tuberculosis by a radiometric procedure and two conventional methods.

Authors:  S H Siddiqi; J E Hawkins; A Laszlo
Journal:  J Clin Microbiol       Date:  1985-12       Impact factor: 5.948

View more
  9 in total

1.  Use of receiver operating characteristic curves to assess the performance of a microdilution assay for determination of drug susceptibility of clinical isolates of Mycobacterium tuberculosis.

Authors:  J Luna-Herrera; G Martínez-Cabrera; R Parra-Maldonado; J A Enciso-Moreno; J Torres-López; F Quesada-Pascual; R Delgadillo-Polanco; S G Franzblau
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-01-25       Impact factor: 3.267

2.  Comparison of flow cytometric and Alamar Blue tests with the proportional method for testing susceptibility of Mycobacterium tuberculosis to rifampin and isoniazid.

Authors:  Roberto S Reis; Ivan Neves; Sergio L S Lourenço; Leila S Fonseca; Maria Cristina S Lourenço
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

3.  Evaluation of the cell growth of mycobacteria using Mycobacterium smegmatis mc2 155 as a representative species.

Authors:  Jorge A Gonzalez-Y-Merchand; Ruben Zaragoza-Contreras; Rosalina Guadarrama-Medina; Addy C Helguera-Repetto; Sandra Rivera-Gutierrez; Jorge F Cerna-Cortes; Leopoldo Santos-Argumedo; Robert A Cox
Journal:  J Microbiol       Date:  2012-06-30       Impact factor: 3.422

Review 4.  Applications of flow cytometry to clinical microbiology.

Authors:  A Alvarez-Barrientos; J Arroyo; R Cantón; C Nombela; M Sánchez-Pérez
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

5.  Editorial commentary: dead or alive: can viability staining predict response to tuberculosis treatment?

Authors:  Stephen D Lawn; Mark P Nicol
Journal:  Clin Infect Dis       Date:  2014-12-23       Impact factor: 9.079

6.  Clinical evaluation of tuberculosis viability microscopy for assessing treatment response.

Authors:  Sumona Datta; Jonathan M Sherman; Marjory A Bravard; Teresa Valencia; Robert H Gilman; Carlton A Evans
Journal:  Clin Infect Dis       Date:  2014-12-23       Impact factor: 9.079

7.  Flow cytometry method for absolute counting and single-cell phenotyping of mycobacteria.

Authors:  David A Barr; Charles Omollo; Mandy Mason; Anastasia Koch; Robert J Wilkinson; David G Lalloo; Graeme Meintjes; Valerie Mizrahi; Digby F Warner; Gerry Davies
Journal:  Sci Rep       Date:  2021-09-20       Impact factor: 4.379

Review 8.  Revisiting the methods for detecting Mycobacterium tuberculosis: what has the new millennium brought thus far?

Authors:  Thales Alves Campelo; Paulo Rafael Cardoso de Sousa; Lucas de Lima Nogueira; Cristiane Cunha Frota; Paulo Renato Zuquim Antas
Journal:  Access Microbiol       Date:  2021-08-02

9.  Fluoromycobacteriophages for rapid, specific, and sensitive antibiotic susceptibility testing of Mycobacterium tuberculosis.

Authors:  Mariana Piuri; William R Jacobs; Graham F Hatfull
Journal:  PLoS One       Date:  2009-03-20       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.